Jamjoom Pharmaceuticals Factory Company SJSC
SAU:4015
Cash Flow Statement
Cash Flow Statement
Jamjoom Pharmaceuticals Factory Company SJSC
| Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||||
| Net Income |
269
|
353
|
316
|
337
|
354
|
371
|
383
|
434
|
463
|
475
|
493
|
|
| Depreciation & Amortization |
25
|
32
|
27
|
28
|
31
|
34
|
37
|
40
|
41
|
42
|
44
|
|
| Other Non-Cash Items |
83
|
98
|
27
|
48
|
44
|
36
|
55
|
40
|
31
|
33
|
22
|
|
| Cash Taxes Paid |
32
|
32
|
16
|
0
|
21
|
21
|
21
|
0
|
23
|
23
|
23
|
|
| Cash Interest Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
|
| Change in Working Capital |
(170)
|
(234)
|
(74)
|
(133)
|
(166)
|
(131)
|
(212)
|
(210)
|
(229)
|
(192)
|
(153)
|
|
| Cash from Operating Activities |
208
N/A
|
249
+20%
|
296
+19%
|
279
-6%
|
264
-6%
|
310
+18%
|
263
-15%
|
304
+16%
|
305
+0%
|
359
+18%
|
406
+13%
|
|
| Investing Cash Flow | ||||||||||||
| Capital Expenditures |
(46)
|
(63)
|
(45)
|
(54)
|
(62)
|
(55)
|
(57)
|
(48)
|
(57)
|
(60)
|
(66)
|
|
| Other Items |
(1)
|
(32)
|
(32)
|
(32)
|
(36)
|
(5)
|
(5)
|
(9)
|
(4)
|
(7)
|
(2)
|
|
| Cash from Investing Activities |
(47)
N/A
|
(95)
-102%
|
(77)
+19%
|
(86)
-11%
|
(98)
-14%
|
(61)
+38%
|
(62)
-2%
|
(57)
+9%
|
(61)
-7%
|
(67)
-10%
|
(69)
-3%
|
|
| Financing Cash Flow | ||||||||||||
| Net Issuance of Debt |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
|
| Cash Paid for Dividends |
0
|
(70)
|
(70)
|
0
|
(175)
|
(217)
|
(217)
|
(319)
|
(214)
|
(242)
|
(242)
|
|
| Other |
(88)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash from Financing Activities |
(88)
N/A
|
(158)
-80%
|
(70)
+55%
|
(70)
0%
|
(175)
-149%
|
(217)
-24%
|
(217)
+0%
|
(319)
-47%
|
(215)
+33%
|
(243)
-13%
|
(243)
0%
|
|
| Change in Cash | ||||||||||||
| Effect of Foreign Exchange Rates |
(2)
|
(2)
|
(5)
|
(6)
|
(4)
|
(6)
|
(6)
|
(1)
|
(2)
|
1
|
2
|
|
| Net Change in Cash |
71
N/A
|
(6)
N/A
|
143
N/A
|
117
-18%
|
(14)
N/A
|
26
N/A
|
(23)
N/A
|
(73)
-223%
|
27
N/A
|
50
+85%
|
96
+91%
|
|
| Free Cash Flow | ||||||||||||
| Free Cash Flow |
162
N/A
|
185
+14%
|
251
+35%
|
225
-10%
|
201
-11%
|
255
+27%
|
206
-19%
|
256
+24%
|
248
-3%
|
298
+20%
|
340
+14%
|
|